观察指标

52例IR

18例SIR

年龄(岁)

23~67 (44.935 ± 10.59^*)

21~71 (46.611 ± 15.39^*)

性别(男/女)

15/37 (28.85%/71.15%)

8/10 (44.44%/55.56%)

病理类型(PTC)

52 (100.0%)

18 (100.0%)

单/多发灶(单/多)

30/22 (57.69%/42.31%)

8/10 (44.44%/55.56%)

癌灶直径(cm)

0.2~4.0 (1.211 ± 0.749^*)

0.2~4.0 (2.061 ± 1.39^*)

淋巴结转移数目(个)

1~17 (5^**)

1~29 (10^**)

淋巴结转移率(%)

8%~75% (33%^**)

25%~84.6% (58.5%^**)

合并HT(是/否)

4/48 (7.69%/92.31%)

2/16 (11.11%/88.89%)

包膜外侵犯(是/否)

23/29 (44.23%/55.77%)

13/5 (72.22%/27.78%)

术后¹³¹I前淋巴结转移(是/否)

5/47 (9.62%/90.38%)

5/13 (27.78%/72.22%)

¹³¹I次数(次)

1~3 (1^**)

1~4 (2^**)

ps-Tg值(ng/ml)

0.42~158 (4.24^**)

1.35~500 (13.425^**)

复发危险分层(低/中/高)

10/19/23 (19.23%/36.54%/44.23%)

0/3/15 (0%/16.67%/83.33%)

TNM分期(I-II/III-IV)

50/2 (96.15%/3.85%)

14/4 (77.78%/22.22%)